Folgen
Keine Story von MediGene AG mehr verpassen.

MediGene AG

Filtern
  • 25.03.2003 – 22:06

    euro adhoc: MediGene AG / MediGene discontinues development of CVLP tumor vaccine (E)

    Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Martinsried/San Diego, March 25, 2003. The biopharmaceutical company MediGene AG (TechDax30: MDG) will discontinue the development project of a CVLP tumor vaccine against cervical cancer. The data obtained from a clinical phase 1/2 trial with the ...